Myeloproliferative Neoplasm — Trials

Myeloproliferative Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,033 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 964
Recruiting: 552
Ph III recruiting: 55
Growth YoY: +9.8%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (699)

clinicaltrialsPublishedShowing 451–466 of 466 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03825796	CPX-351 Plus Enasidenib for Relapsed AML	active not recruiting	Phase 2	2	Jonsson Comprehensive Cancer CenterOTHER	1	Sep 28, 2023	clinicaltrials
NCT05805098	Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML(VHA)	recruiting	Phase 2 / Phase 3	60	The First Affiliated Hospital of Soochow UniversityOTHER	1	Apr 7, 2023